PROFUND ADVISORS LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1129919 BETHESDA, MD

Position in DYN

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,489,161

-$207,590 QoQ

Shares Held

82,138

-5.3% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. DYN ranks #51 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,489,161	82,138	-5.3%	Shares	Sole	2026-04-27
2025-12-31	$1,696,751	86,746	+88.7%	Shares	Sole	2026-02-06
2025-09-30	$581,647	45,980	+94.5%	Shares	Sole	2025-11-06
2025-06-30	$225,071	23,642	-23.0%	Shares	Sole	2025-08-07
2025-03-31	$321,320	30,719	-5.8%	Shares	Sole	2025-05-08
2024-12-31	$767,914	32,594	-0.9%	Shares	Sole	2025-02-14
2024-09-30	$1,181,480	32,892	+20.0%	Shares	Sole	2024-11-14
2024-06-30	$967,687	27,421	-48.7%	Shares	Sole	2024-08-13
2024-03-31	$1,517,360	53,447	+98.2%	Shares	Sole	2024-05-08
2023-12-31	$358,594	26,962	+13.3%	Shares	Sole	2024-02-14
2023-09-30	$213,185	23,793	+9.8%	Shares	Sole	2023-11-13
2023-06-30	$243,697	21,662	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.